This prospective descriptive study investigated pain characteristics in 20 outpatients with end-stage liver disease (ESLD) who were approaching the end of life, described variability in pain between and within patients, and described the pharmacological and nonpharmacological pain management strategies used. The instruments we utilized were the Brief Pain Inventory (BPI) and the self-care behaviour (SCB) log for pain. Data were collected once a month over a six-month period. BPI severity of, and interference from pain mean scores ranged from 5.52 to 6.03 and 5.36 to 6.64, respectively. The top three pain-relieving behaviours reported by patients were “taking pain medication,” “taking a nap,” and “asking for help.” Pain medication intake differed between patients who were pursuing a liver transplant and those who were not eligible for one. If we are to effectively improve care for ESLD patients, it is essential that we understand the ways in which these patients experience pain and the pain management strategies they employ.
HoyertD.L., XuJ.Q.Deaths: preliminary data for 2011. National Vital Statistics Reports 61(6).Hyattsville (MD): National Center for Health Statistics; 2012.
2.
SUPPORT Principal Investigators.A controlled trial to improve care for seriously ill hospitalized patients: the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment (SUPPORT).JAMA1995; 274(20): 1591–1598.
3.
RothK., LynnJ., ZhongZ.Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.J Am Geriatr Soc2000; 48(5 Suppl): S122–S130.
4.
DesbiensN.A., WuA.W., BrosteS.K.Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations.Crit Care Med1996; 24(12): 1953–1961.
5.
DesbiensN.A., WuA.W.Pain and suffering in seriously ill hospitalized patients.J Am Geriatr Soc2000; 48(5 Suppl): S183–S186.
6.
LynnJ., TenoJ.M., PhillipsR.S.Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.Ann Intern Med1997; 126(2): 97–106.
RatcliffeJ., LongworthL., YoungT.Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study.Liver Transpl2002; 8(3): 263–270.
9.
YounossiZ., BoparaiN., PriceL.L.Health-related quality of life in chronic liver disease: the impact of type and severity of disease.Am J Gastroenterol2001; 96(7): 2199–2205.
10.
Pérez-San-GregorioMá, Martin-RodriquezA., Domínguez-CabelloE.Quality of life and mental health comparisons among liver transplant recepients and cirrhotic patients with different self-perceptions of health.J Clin Psychol Med Settings2013; 20(1): 97–106.
11.
ChandokN., WattK.D.S.Pain management in the cirrhotic patient: the clinical challenge.Mayo Clin Proc2010; 85(5): 451–458.
12.
LarsonA.M., CurtisJ.R.Integrating palliative care for liver transplant candidates.JAMA2006; 295(18): 2168–2176.
13.
MediciV., RossaroL., WegelinJ.A.The utility of the Model for End-Stage Liver Disease score: a reliable guide for liver transplant candidacy and for select patients, simultaneous hospice referral.Liver Transpl2008; 14(8): 1100–1106.
14.
AntakiF., LukowskiA.The Model for End-Stage Liver Disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.J Clin Gastroenterol2007; 41(4): 412–415.
15.
KamathP.S., WiesnerR.H., MalinchocM.A model to predict survival in patients with end-stage liver disease.Hepatology2001; 33(2): 464–470.
16.
KamathP.S., KimW.R.Is a change in MELD score a better indicator of mortality than baseline MELD score?Liver Transpl2003; 9(1): 19–21.
HansenL., LeoM., ChangM.Symptom distress in patients with end-stage liver disease toward the end of life.Gastroenterol Nurs; forthcoming.
21.
DautR.L., CleelandC.S., FlaneryR.C.Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.Pain1983; 17(2): 197–210.
22.
CowanD.T., Wilson-BarnettD.J., GriffithsP.A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.Pain Med2005; 6(2): 113–121.
23.
ChangV.T., HwangS.S., KasimisB.Longitudinal documentation of cancer pain management outcomes: a pilot study at a VA medical center.J Pain Symptom Manage2002; 24(5): 494–505.
24.
TanG., JensenM.P., ThornbyJ.I.Validation of the Brief Pain Inventory for chronic nonmalignant pain.J Pain2004; 5(2): 133–137.
WangX.S., CleelandC.S., MendozaT.R.The effects of pain severity on health-related quality of life: a study of Chinese cancer patients.Cancer1999; 86(9): 1848–1855.
30.
SimoneC.B., VapiwalaN., HampshireM.K.Palliative care in the management of lung cancer: analgesic utilization and barriers to optimal pain management.J Opioid Manag2012; 8(1): 9–16.
31.
ErsekM., KraybillB.M., PenA.D.Factors hindering patients’ use of medications for cancer pain.Cancer Pract1999; 7(5): 226–232.
32.
KaplanR., SlywkaJ., SlagleS.A titrated morphine analgesic regimen comparing substance users and non-users with AIDS-related pain.J Pain Symptom Manage2000; (19): 265–273.
33.
SchiefferB.M., PhamQ., LabusJ.Pain medication beliefs and medication misuse in chronic pain.J Pain2005; 6(9): 620–629.
34.
RileyTR3rdKochK.Characteristics of upper abdominal pain in those with chronic liver disease.Dig Dis Sci2003; 48(10): 1914–1918.
35.
VickersA.J., CroninA.M., MaschinoA.C.Acupuncture for chronic pain: individual patient data meta-analysis.Arch Intern Med2012; 172(19): 1444–1453.
36.
LuW., RosenthalD.S.Acupuncture for cancer pain and related symptoms.Curr Pain Headache Rep2013; 17(3): 321–328.
37.
HopeA.A., MorrisonR.S.Integrating palliative care with chronic liver disease.J Palliat Care2011; 27(1): 20–27.
38.
HansenL., SasakiA., ZuckerB.End-stage liver disease: challenges and practice implications.Nurs Clin North Am2010; 45(3): 411–426.
39.
DavisH., De-NourA.K., ShouvalD.Psychological distress in patients with chronic, nonalcoholic, uncomplicated liver disease.J Psychosom Res1998; 44(5): 547–554.
40.
De BonaM.P., PontonP., ErmaniP.The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation.J Hepatol2000; 33(4): 609–615.
41.
McMillanS.C., SmallB.J., HaleyW.E.Improving hospice outcomes through systematic assessment: a clinical trial.Cancer Nurs2011; 34(2): 89–97.
42.
HigginsonI.J., EvansC.J.What is the evidence that palliative care teams improve outcomes for cancer patients and their families?Cancer J2010; 16(5): 423–435.
43.
El-JawahriA., GreerJ.A., TemelJ.S.Does palliative care improve outcomes for patients with incurable illness? A review of the evidence.J Support Oncol2011; (9): 87–94.
